Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Myelodysplastic syndrome drug-resistant cell model as well as construction method and application thereof

A drug-resistant cell and construction method technology, applied in the field of myelodysplastic syndrome drug-resistant cell model and its construction, can solve the problem of unclear drug resistance mechanism of demethylated drugs, and achieve the effect of stable drug resistance

Pending Publication Date: 2022-08-09
LUOYANG CENT HOSPITAL
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, the mechanism of resistance to hypomethylating drugs is still unclear

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Myelodysplastic syndrome drug-resistant cell model as well as construction method and application thereof
  • Myelodysplastic syndrome drug-resistant cell model as well as construction method and application thereof
  • Myelodysplastic syndrome drug-resistant cell model as well as construction method and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0027] This embodiment provides a myelodysplastic syndrome drug-resistant cell model and its construction method and use.

[0028] 1. Materials and methods

[0029] 1. Cell lines and main reagents

[0030] Human MDS cell lines (SKM-1, MOIM-13) were purchased from the National Experimental Cell Resource Sharing Service Platform, passaged and preserved in the Hematology Laboratory of Luoyang Central Hospital;

[0031] Fetal bovine serum (Hycolne, USA), RPMI-1640 medium (Hycolne, USA), Penicillin-streptomycin (Invitrogen, USA), Glutamine (Invitrogen, USA), Cell Counting Kit-8 (Beijing Soleibo) Technology Co., Ltd.), Annexin V-FITC Apoptosis Detection Kit (Beijing Soleibao Technology Co., Ltd.), azacitidine (TaKaRa Company).

[0032] 2. Experimental method

[0033] (1) Cell culture

[0034] SKM-1 and MOIM-13 cells used in this experiment were cultured with RPMI-1640+15% fetal bovine serum medium, and 1% double antibody (penic-streptomycin) and 1% glutamine were added at the sa...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention belongs to the technical field of cell drug resistance, and relates to a myelodysplastic syndrome drug-resistant cell model and a construction method and application thereof, and the cell model is established by adopting a method of gradually increasing drug concentration and intermittently inducing and is formed by azacitidine induction. According to the present invention, the MDS AZA-resistant cell strains SKM-1-AZA and MOIM-13-AZA are successfully induced, the growth and the drug resistance of the MDS AZA-resistant cell strains are stable, and the experimental basis is provided for the further discussion of the drug resistance mechanism.

Description

technical field [0001] The invention belongs to the technical field of cell drug resistance, and relates to a myelodysplastic syndrome drug resistance cell model and a construction method and application thereof. Background technique [0002] Myelodysplastic Syndrome (MDS) is a group of clonal hematopoietic stem cell diseases characterized by one or more lineages of abnormal hematopoiesis and ineffective hematopoiesis. The probability of transformation into acute myeloid leukemia is as high as 30%. Studies have found that the pathogenesis of MDS is closely related to epigenetic abnormalities, and DNA methylation abnormalities are the most common epigenetic changes in MDS. In recent years, epigenetic therapy represented by the demethylating drug azacitidine (AZA) has shown good efficacy in MDS. However, the phenomenon of demethylation drug resistance is inevitable. Most patients develop drug resistance within 2 years of treatment response. The median overall survival (OS) of...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C12N5/0789
CPCC12N5/0647C12N2501/999
Inventor 王慧睿毛慧云郭淑利刘思哲安万花
Owner LUOYANG CENT HOSPITAL
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com